Psychiatric-Medical Comorbidity
The Psychiatric-Medical Comorbidity section will focus on the prevalence and impact of psychiatric disorders in patients with chronic medical illness as well as the prevalence and impact of medical disorders in patients with chronic psychiatric illness.
Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research
Introduction
Beginning in the 1980s, reports that psychosocial stress and depression following myocardial infarction (MI) were linked to prognosis accumulated [1] [2] [3] [4] [5] . The increasing number of studies showing links between post-MI depres-sion and prognosis suggested that identifying and treating depression in MI patients could contribute to improving survival rates and overall prognosis.
In the 25 years since these first investigations, much research has been done in this field, which has been summarized in several meta-analyses [6] [7] [8] . This research showed that depressed cardiac patients have an increased risk of both fatal and nonfatal events (including patients with depressive disorder and patients with elevated symptoms of Available online at www.sciencedirect.com General Hospital Psychiatry 33 (2011) 203 -216 depression based on self-report questionnaires) compared with those without depression. Barth et al. [6] performed a meta-analysis on 29 studies concerning patients with coronary heart disease (CHD), most of which were MI patients. They found that depression in MI patients was associated with a 2.0 to 2.6 times higher risk of mortality. Similarly, in a meta-analysis of 22 studies, Van Melle et al. [8] found an increased risk of 2.0 to 2.5 of poor cardiac or mortality outcomes within 2 years after an MI in patients with depression compared with nondepressed patients. The most recent meta-analysis by Nicholson et al. [7] reviewed studies published up to 2004 and reported that depressed post-MI patients had a 2.1 times higher risk of mortality than nondepressed patients. Hence, in summary, previous meta-analyses demonstrated that depressed post-MI patients have a 2.0 to 2.6 times increased risk of adverse outcomes compared with nondepressed post-MI patients.
A fair number of important studies on post-MI depression and (cardiac) prognosis have been published in the 7 years since previous literature searches. In addition, none of the existing meta-analyses have statistically investigated whether the association of depression with mortality or cardiac events changes over time, as has been suggested earlier [8, 9] . This is an important question, as new insights in study design and statistical methodology as well as advances in the treatment and prevention of MI in recent years can affect the nature and strength of the association between post-MI depression and prognosis.
Therefore, the main objective of this study was to perform a new meta-analysis to summarize the association between post-MI depression and prognosis, defined as all-cause mortality, cardiac mortality and cardiac events that occurred within 24 months after the index MI. A secondary goal was to investigate whether the strength of the relationship between depression and cardiac outcomes has changed over the years and whether or not methodological factors influence this relationship.
Methods

Literature search
A literature search was performed on January 5, 2011, to identify prognostic studies that investigated the association between post-MI depression and (cardiovascular) prognosis published since our previous literature search in January 2004 [8] . The combined search results included literature published since 1975. Relevant articles were selected from the electronic databases Medline (PubMed), Embase and PsycINFO without language restrictions. For this purpose, search terms related to depression and MI were used and customized to the search strategies of each database. Full-search strings for each database are listed in Appendix 1. In addition to the database searches, major reviews and relevant articles were cross-referenced. When necessary, additional information was requested from authors by e-mail.
Study selection
Inclusion and exclusion criteria
Studies that met the following criteria were eligible for inclusion: patients were hospitalized for MI; a validated depression rating scale or structured diagnostic interview was used; depression was measured within 3 months after the MI; studies were prospective, reporting on (cardiovascular) prognosis in depressed versus nondepressed patients; study outcome was all-cause mortality, cardiac mortality or cardiac events; and the end point was within 24 months after the index MI. For the end-point cardiac events, studies that reported on cardiac death, cardiac arrest, recurrent MI, cardiac rehospitalization or a combination of the above were included. Depression was defined as either depressive disorder or elevated symptoms of depression.
Selection of studies identified by the literature search was done by three independent raters (J.v.M., P.d.J. and A.M.) in two phases. First, a title abstract review was performed, in which studies that clearly did not meet the inclusion criteria were excluded. Second, full texts were retrieved and reviewed for the articles that were selected as potentially eligible for inclusion in the title-abstract review. In the review process, reviews, meta-analyses, comments, letters, editorials, case reports and design reports of studies as well as studies that did not include depression as a mood state (but, for example, ST-segment depression) were excluded.
Only studies on data of MI patients were included to create a relatively homogeneous group of subjects. Furthermore, the end point was chosen to be within 2 years after MI, as we were interested in relatively short-term effects of post-MI depression on prognosis. Most mortality and new events after MI occur within the first few months, so it was expected that any association with post-MI depression would be evident by 2 years. By using a 2-year follow-up period, relevant studies with varying follow-up durations could best be compared. If studies reported outcomes later than 2 years after the index MI, authors were contacted to request data on 2-year outcomes.
When multiple articles were based on the same dataset, those with the best methodological quality or those that were most informative were selected (i.e., more subjects, longer follow-up, etc.). However, when multiple articles were based on the same subjects, but reported on different, not overlapping outcomes, they were all included.
When studies included MI patients as a subgroup of acute coronary syndrome, and it was recorded whether patients had unstable angina or MI, the authors were asked for depression and outcome data for MI patients only.
Quality assessment
Reporting the quality of studies included in metaanalyses is recommended by experts [10] , as the quality of the results of a meta-analysis largely depends on the quality of included studies. In addition, quality assessment may be helpful in deciding which variables measured in the studies of the meta-analysis could be used in subgroup or sensitivity analyses. Therefore, included articles were assessed according to the following six methodological quality criteria: (1) sample size of each group (preferably at least 25 patients per group); (2) representativeness of the population (i.e., whether the sample had any specific inclusion or exclusion criteria such as those based on age or gender); (3) whether there was more than 25% loss to followup; (4) whether studies controlled for at least three of the following: hypertension, smoking, hypercholesterolemia, diabetes mellitus, left ventricular ejection fraction (LVEF) or previous MI; (5) whether clinical end points were scored adequately, that is, by means of central death registry, chart review or independent blinded end point committee and (6) whether depression was measured using a structured diagnostic interview or a self-report instrument.
Data analysis
Data analyses for the summary estimate of the odds ratios (ORs) were performed separately for three outcomes: allcause mortality, cardiac mortality and cardiac events. First, data from the included studies were pooled. Reported results were converted into raw data (2×2 tables) and dichotomized outcomes. Then, pooled ORs and 95% confidence intervals (CIs) were calculated using MIX 1.7, a statistical package designed for performing meta-analyses [11] , using a random effects model [12] . When studies reported both clinically diagnosed major depressive disorder and depressive symptoms, data on major depressive disorder were included. To test between-study variance, heterogeneity tests were Analyses on all-cause mortality: 17
Analyses on cardiac mortality: 6
Analyses on cardiac events: 18 performed using the Q and I 2 statistics. Possible publication bias was investigated using funnel plots and Egger tests. Second, to investigate whether the association between post-MI depression and cardiac prognosis changed over time, individual, unadjusted ORs were used and changes over time were investigated using STATA 11 (Statacorp LP, College Station, TX, USA). Different meta-regression models were applied to investigate whether there was any trend in the ORs over time. Null, linear, quadratic and cubic models were applied, and best-fitting models were selected using the Schwarz Bayesian Information Criterion (BIC). The year of the start of data collection (study start) was used as independent variable instead of the year of publication, as there may be a considerable time lag between the period a study is performed and the time it is published. Analyses were weighted for the number of subjects in each study, in such a way that larger studies contributed more to the pooled OR than smaller studies.
Third, subgroup analyses were performed in MIX 1.7 for two methodological differences between studies: type of depression instrument (structured diagnostic interview vs. self-rating) and number of subjects per study (dichotomized smaller N vs. larger N). For each outcome, studies were divided into subgroups, and separate ORs were calculated. ORs were then compared with a χ 2 test.
Results
Literature search and selection
The literature search resulted in 6,095 unique titles/ abstracts. Cross-referencing and personal contacts resulted in an additional 48 potentially eligible articles. After the review and selection process, 31 articles reporting on 29 studies were selected and included, reporting on 16,889 patients (5,353 depressed and 11,536 nondepressed) and representing 41 different analyses. Most of the ineligible articles were excluded because they were not based on original data, such as reviews, case-reports and editorials; because they did not select subjects based on the presence of MI; or because they did not include depression as an emotional state or as a risk factor for poor prognosis. Interrater reliability between the two sets of reviewers (J.v.M.-P.d.J. and P.d.J.-A.M.) was calculated for the full-text review (Cohen's k=0.80 and 0.86, respectively). Fig. 1 is a flowchart of the search results.
Ten authors were contacted to request additional information. Requests were made for outcome data at 24 months post-MI, data for depressed patients only instead of patients with depression or anxiety, duration of follow-up, exact number of events in depressed versus nodepressed groups, data on MI patients only instead of acute coronary syndrome patients, timing of depression measurement after the MI, year in which the study started, loss to follow-up and which depression rating instrument was used. Seven authors provided the requested information. Three authors could not answer, or did not respond to the request, which in these cases meant their studies could not be included in the meta-analysis.
Main study characteristics
In Table 1 , the main study characteristics of included articles are summarized. Collectively, the combined samples included 16,889 patients. Mean patient age at the time of the index MI was 61 years (range, 54-65 years). Twenty-six percent of patients were women, and mean follow-up time was 16 months, ranging from 1 week to 24 months. The proportion of patients with major depression or patients scoring above the cutoff of self-rating instruments ranged from 5 to 69% (average 28%). This proportion was relatively high in some studies, as they purposefully included more depressed patients. The average percentage of all-cause mortality was 9% (range, 2%-21%); cardiac mortality, 5% (0.5%-10%) and cardiac events, 21% (range, 5%-47%).
Association between post-MI depression and prognosis
Seventeen studies, consisting of 10,362 patients, reported on all-cause mortality. A total of 892 patients died within 2 years after the index MI. The pooled OR of all-cause mortality after MI in 3,053 depressed patients compared with 7,309 nondepressed patients was 2.25 (95% CI, 1.73-2.93; Pb.001; Fig. 2A Cardiac events (fatal and nonfatal) were reported in 18 studies, consisting of 10,119 patients. A total of 2,247 patients had another cardiac event within 2 years after the index MI. The pooled OR of cardiac mortality after MI in 2,946 depressed patients compared with 7,173 nondepressed patients was 1.59 (95% CI, 1.37-1.85; Pb.001; Fig. 2C ). The 18 studies were statistically homogeneous [Q=24.5, P=.11; I 2 =30.64 (95% CI, 0-60.8)].
For the three meta-analyses, funnel plots and Egger tests showed no evidence of publication bias. Table 2 summarizes the three meta-analyses, including the heterogeneity and publication bias tests. Funnel plots are shown in Fig. 3A -C.
Adjusted associations
Eight studies reported associations adjusted for baseline demographic and cardiac disease severity variables. These adjusted and unadjusted ORs were compared to gain insight into the role of cardiac disease severity and other confounding variables in the association between post-MI depression and prognosis. The studies reporting adjusted associations were too few and heterogeneous to pool by meta-analysis.
Therefore, adjusted and unadjusted associations as they were reported in the original articles are simply listed in Table 3 . Note that the associations are not necessarily reported as ORs but also as hazard ratios. However, when the frequency of events among subjects is low, which is the case with mortality or cardiac events, these numbers are roughly comparable [41, 42] . In seven of the eight studies, adjusted associations were smaller than unadjusted associations. The attenuation ranged from 4% to 65% and was, on average, 21%.
Secondary analyses
Changes in ORs over time
There was no association between the year of study start and the OR for the outcome all-cause mortality. Fig. 4A shows the ORs against time. For the outcome cardiac mortality, the number of studies (6) was too small to perform a meta-regression.
There was a significant linear association between the year of study start and the OR for the outcome cardiac events 
Differences between structured diagnostic interviews and self-rating instruments
For the outcome all-cause mortality, 6 studies (n=2,280) used interview-based instruments to assess depression, and 11 studies (n=8,082) used self-report instruments. The OR for interview-based instruments was 3.69 (95% CI, 2.05-6.63; Pb.001), and for self-report instruments, it was 1.83 (95% CI, 1.51-2.23; Pb.001), which was significantly different (χ 2 =2.22, P=.03).
All studies reporting on cardiac mortality used self-rating instruments, so no subgroup analysis could be performed.
For the outcome cardiac events, 7 studies (n=1,260) used interview-based instruments to assess depression, and 11 studies (n=8,859) used self-report instruments. The OR for interview-based instruments was 1.96 (95% CI, 0.99-3.89; Pb.05), and for self-report instruments, it was 1.53 (95% CI, 1.35-1.73; Pb.001), which was not significantly different (χ 2 =0.70, P=.48).
There were no changes in the frequency of use of selfreport instruments and interviews over time. 
Differences between smaller studies and larger studies
Studies reporting on all-cause mortality were divided into two subgroups. The subgroup of nine studies with each less than 400 subjects contained 2,012 patients, and the subgroup of eight studies with each more than 400 subjects contained 8,350 patients. The OR for the smaller studies was 2.25 (95% CI, 1.38-3.66), and for the larger studies, it was 2.30 (95% CI, 1.65-3.20). There was no significant difference between the ORs (χ 2 =0.07, P=.94).
For the outcome cardiac mortality, the studies were again divided into two subgroups. The subgroup of three studies with each less than 330 subjects contained 852 patients, and the subgroup of three studies with each more than 330 subjects contained 2,491 patients. The OR for the smaller studies was lower than that for the larger studies [1.90 (95% CI, 1.06-3.48; P=.03) vs. 3.92 (95% CI, 2.24-6.88] Pb.001)], and this difference was not significant but showed a trend (χ 2 =1.76, P=.08).
Finally, studies reporting on cardiac events were divided into two equal subgroups with nine studies. The subgroup of nine studies with each less than 400 subjects contained 1,700 patients, and the subgroup of nine studies with each more than 400 subjects contained 8,419 patients. The OR for the smaller studies was higher than that for the larger studies [1.74 (95% CI, 1.01-2.98; P=.04) vs. 1.53 (95% CI, 1.37-1.71; Pb.001)]. The difference was not significant (χ 2 =0.45, P=.65). Finally, for all three outcome types, there were no changes of study size over time.
Quality assessment
Studies were evaluated on six quality aspects. First, the preferred sample size was at least 25 patients in the depressed and in the nondepressed groups. In all studies, the number of nondepressed patients was over 25 (average n=400; range, 54-1823). The number of depressed patients was lower than 25 in three studies (average n=175; range, 4-920). Second, studies were assessed on representativeness of the population. The majority of studies (19) did not have any unusual inclusion or exclusion criteria. Exclusion criteria such as those based on the presence of dementia, the presence of other major psychiatric disorders and being unable to speak the researchers' language were not considered unusual. Third, it was assessed whether there was more than 25% loss to follow-up. Thirteen studies did not have any loss to follow-up. In the remaining studies, loss to follow-up was, on average, 5% (range, 0.2%-17%), and none reported loss to follow-up over 25%. Six studies did not report the number of patients lost to follow-up. Fourth, it was assessed whether studies adjusted for at least three of the following cardiac risk factors in their adjusted analyses: hypertension, smoking, hypercholesterolemia, diabetes mellitus, LVEF or previous MI. Twelve analyses were adjusted for at least three of these risk factors, 16 analyses were not adjusted for at least three of these factors and 4 analyses were not adjusted or did not report the variables they adjusted for. Fifth, it was assessed whether clinical end points were scored adequately, that is, by means of central death registry, chart review or independent blinded end-point committee. Three studies did not report how they scored the clinical end point, and three other studies did not use an adequate method (but patient or family selfreports only). Finally, it was assessed whether depression was measured using a structured diagnostic interview or a self-report instrument. The majority of the studies (17) used self-rating instruments, six studies used a standardized structured clinical interview and four studies used both. An overview of the quality assessment of the included articles is listed in Table 4 .
The effects of the quality criteria on the association between post-MI depression and prognosis for sample size, type of depression measurement instrument and adjustment for confounders were assessed in the secondary analyses. These analyses revealed that sample size did not affect the strength of the association reported, that studies using structured diagnostic interviews had higher ORs for all-cause mortality than did studies using self-rating instruments and that the association between post-MI depression and prognosis was attenuated when adjusted for confounders. The other quality criteria were assessed in sensitivity analyses. These analyses revealed no differences in results with regard to specific inclusion or exclusion criteria, loss to follow-up or end-point scoring method.
Discussion
Association between post-MI depression and prognosis
Unadjusted ORs show that patients with a post-MI depression have a 2.25 times increased risk of all-cause mortality, a 2.71 times increased risk of cardiac mortality and a 1.59 times increased risk of new cardiac events. These ORs are similar to those found in earlier meta-analyses [6, 7] .
Individual adjusted associations were lower (on average, 21%) than unadjusted associations in all but one of the eight studies reporting associations adjusted for baseline demographic and medical variables. This attenuation was found in previous similar meta-analyses of the association between depression in cardiac patients and prognosis. A meta-analysis of MI patients, for example, found a reduction in association of 41% after adjustment for possible confounders [7] Others also found a reduction, though less pronounced [6, 8] . One possible explanation may be reverse causality: depression does not cause cardiac events or death, but the severity of the cardiac disease causes both a poorer prognosis and more depressive symptoms [7] . The fact, however, that after adjustment for disease severity, depression is still associated with poorer prognosis suggests that it is an independent risk factor. Most likely, the association is bidirectional. In addition, other variables, such as smoking and age, may affect the association, not just as confounders, but also as mediators of the association. When there is reverse causality or confounding, the pooled ORs adjusted for disease severity and other confounders will probably turn out lower than unadjusted pooled ORs [43] .
Unfortunately, we could not provide a pooled association that is consistently adjusted for the same variables across studies, as each study adjusts for a different set of variables. The only way to solve this problem is to perform a metaanalysis of individual patient data of the original studies and adjust for the same variables.
Changes in ORs over time
ORs were expected to decline over time, and such a decline was found for the outcome cardiac events, showing a small but significant decline of about 0.1 for each progressing year. This means that the apparent effect of depression on new cardiac events has become smaller. Too little is known so far about the mechanisms of this association to be able to explain this decline. For the outcomes all-cause mortality and cardiac mortality, there were no significant changes in ORs over time. No mentionable changes were found in the frequencies of mortality, cardiac events or depression that could help explain the fact that the association did decline for cardiac events, but not for mortality.
Subgroup analyses: depression measurement and sample size
The two subgroup analyses, based on the type of depression measurement instrument and number of subjects per study, revealed interesting results. The ORs for diagnostic interviews were significantly higher than those for self-rating instruments for all-cause mortality. This makes sense, as the fact that studies using (semi-)structured diagnostic interviews categorize patients with more severe depressive symptoms as depressed, whereas studies using self-rating instruments may include more patients, as they often include patients with mild and moderate depressive symptoms as well. Major depression is likely to have a stronger association with adverse outcomes than less severe depressive symptoms when there is a dose-response relationship. In addition, it has been suggested that standard cutoff scores for self-rating instruments lead to an overestimation of depression severity. More nondepressed patients may be rated as depressed than when structured diagnostic interviews are used. This can explain why the strength of the association between post-MI depression and prognosis is weaker for depression assessed with self-rating instruments than for structured interview-based instruments.
Contrasting results were found in other meta-analyses on depression in CHD patients. Nicholson et al. [7] found that studies using clinical measures of depression reported weaker associations between depression and prognosis than did studies using symptom assessments. Barth et al. [6] found no difference in the association between post-MI depression and prognosis as measured with (semi-)structured diagnostic interviews or self-report instruments and prognosis. In the current meta-analysis, smaller studies did not report significantly higher ORs than did larger studies, and sample size did not change over time. This indicates that publication bias did not affect the results.
Conclusion
This meta-analysis shows that depression has been consistently associated with a worse prognosis after MI over the past 25 years. The association between post-MI depression and impaired prognosis is stable over time for mortality, but shows a slight decline for new cardiac events. These results once again emphasize that depression in post-MI patients not only deserves attention as a debilitating condition in itself but also remains a signal of an increased risk of cardiovascular events and mortality.
